Crown Equity Holdings Inc. (OTCBB:CRWE) is pleased to report its financial results for the nine month period ending September 30, 2010. Revenue for the nine months totaled $1,073,383 compared to $418,959 during 2009. The Company incurred an operating loss of $54,527 for the nine months ending September 30, 2010 compared to an operating loss of $36,923 during the same period in 2009. Net loss of $343,049 for the nine months ending September 30, 2010 compared to a net loss of $29,379 for the same period in 2009. The net loss in 2010 was attributed mostly to an unrealized loss of $307,544 on securities held by the Company.
“Our continued progress in operations including an operating profit of $7,251 during the last quarter shows a continued growth in our business,” commented Kenneth Bosket, President and CEO of Crown Equity Holdings Inc. “Not only do our financial results show strong growth during this year but our continued investment in infrastructure will support our future growth,” stated Bosket.
Crown Equity Holdings Inc. is a consulting organization which provides and assists small business owners with the knowledge required in taking their company public, and has re-focused its primary vision with its aligned group of independent website divisions to providing media advertising services, as a worldwide online media advertising publisher, dedicated to the distribution of quality branding information, as well as search engine optimization for its clients. The company announced in June of this year its 1- 10 forward stock split.
R.G. Barry Corporation (NASDAQ:DFZ), recently said that its fiscal 2011 first quarter net sales and profits were buoyed by early holiday shipments to retailers. DFZ had an 81 percent net earnings increase to $4.1 million, or $0.37 per basic and diluted share, from $2.3 million, or $0.21 per basic share and diluted share, in the first quarter of fiscal 2010.
R.G. Barry Corporation, the Dearfoams company, is one of the world�s leading developers and marketers of accessory footwear.
Flextronics (NASDAQ:FLEX) announced recently that it has called for redemption all of its outstanding 6 1/4 % Senior Subordinated Notes due 2014. As of November 15, 2010, there are $302 million outstanding in aggregate principal amount of the 6 1/4 % Notes.
Headquartered in Singapore, Flextronics is a leading Electronics Manufacturing Services provider focused on delivering complete design, engineering and manufacturing services to automotive, computing, consumer, industrial, infrastructure, medical and mobile OEMs.
PROLOR Biotech, Inc. (AMEX:PBTH), a company developing next generation biobetter therapeutic proteins, recently announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to hGH-CTP, PROLOR�s longer-acting version of human growth hormone for the treatment of growth hormone deficiency. hGH-CTP is currently in a Phase II clinical trial.
PROLOR Biotech, Inc. is a biopharmaceutical company applying unique technologies, including its patented CTP technology, primarily to develop longer-acting, biobetter, proprietary versions of already-approved therapeutic proteins that currently generate billions of dollars in annual global sales.
No comments:
Post a Comment